Literature DB >> 28987552

Is Infection an Independent Risk Factor for Venous Thromboembolism? A Population-Based, Case-Control Study.

Kevin P Cohoon1, Aneel A Ashrani2, Daniel J Crusan3, Tanya M Petterson3, Kent R Bailey3, John A Heit4.   

Abstract

BACKGROUND: The independent association of recent infection with venous thromboembolism is uncertain. The study aims were to test both overall infection (site unspecified) and specific infection sites as potential risk factors for deep vein thrombosis and pulmonary embolism adjusting for other known venous thromboembolism factors.
METHODS: By using Rochester Epidemiology Project resources, we identified all Olmsted County, Minnesota, residents with objectively diagnosed incident deep vein thrombosis or pulmonary embolism over the 13-year period 1988 to 2000 (cases; n = 1303) and 1 to 2 residents without venous thromboembolism matched to each case on age, sex, and incident venous thromboembolism date (controls; n = 1494). Using conditional logistic regression, we tested recent infection and infection site(s) for an association with venous thromboembolism, adjusting for body mass index, smoking, current/recent hospitalization with/without surgery, nursing home confinement, active cancer, trauma/fracture, leg paresis, prior superficial vein thrombosis, transvenous catheter/pacemaker, ischemic heart disease, congestive heart failure, chronic lung or renal disease, serious liver disease, asthma, diabetes mellitus, hormone therapy, and pregnancy/postpartum.
RESULTS: A total of 513 cases (39.4%) and 189 controls (12.7%) had an infection in the previous 92 days (odds ratio, 4.5; 95% confidence interval, 3.6-5.5; P < .0001). In a multivariable analysis adjusting for common venous thromboembolism risk factors, pneumonia and symptomatic urinary tract, oral, intra-abdominal, and systemic bloodstream infections were associated with significantly increased odds of venous thromboembolism.
CONCLUSIONS: Infection as a whole and specific infection sites in particular are independent risk factors for venous thromboembolism and should be considered as potential indications for venous thromboembolism prophylaxis.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Deep vein thrombosis; Epidemiology; Infection; Pulmonary embolism; Thrombophlebitis

Mesh:

Year:  2017        PMID: 28987552      PMCID: PMC5817009          DOI: 10.1016/j.amjmed.2017.09.015

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  30 in total

1.  Association between pneumococcal pneumonia and venous thromboembolism in hospitalized patients: A nationwide population-based study.

Authors:  Yu-Guang Chen; Te-Yu Lin; Wen-Yen Huang; Cheng-Li Lin; Ming-Shen Dai; Chia-Hung Kao
Journal:  Respirology       Date:  2015-02-27       Impact factor: 6.424

2.  Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Susan R Kahn; Wendy Lim; Andrew S Dunn; Mary Cushman; Francesco Dentali; Elie A Akl; Deborah J Cook; Alex A Balekian; Russell C Klein; Hoang Le; Sam Schulman; M Hassan Murad
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.

Authors:  Teresa C Horan; Mary Andrus; Margaret A Dudeck
Journal:  Am J Infect Control       Date:  2008-06       Impact factor: 2.918

4.  The patient record in epidemiology.

Authors:  L T Kurland; C A Molgaard
Journal:  Sci Am       Date:  1981-10       Impact factor: 2.142

5.  Neutrophil extracellular traps form predominantly during the organizing stage of human venous thromboembolism development.

Authors:  A S Savchenko; K Martinod; M A Seidman; S L Wong; J I Borissoff; G Piazza; P Libby; S Z Goldhaber; R N Mitchell; D D Wagner
Journal:  J Thromb Haemost       Date:  2014-06       Impact factor: 5.824

6.  Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study.

Authors:  John A Heit; W Michael O'Fallon; Tanya M Petterson; Christine M Lohse; Marc D Silverstein; David N Mohr; L Joseph Melton
Journal:  Arch Intern Med       Date:  2002-06-10

7.  Regulation of macrophage procoagulant responses by the tissue factor cytoplasmic domain in endotoxemia.

Authors:  Jasimuddin Ahamed; Frank Niessen; Toru Kurokawa; Young Kyung Lee; Gourab Bhattacharjee; James H Morrissey; Wolfram Ruf
Journal:  Blood       Date:  2007-03-01       Impact factor: 22.113

8.  Venous thromboembolism in adult hospitalizations - United States, 2007-2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-06-08       Impact factor: 17.586

9.  Tissue factor pathway inhibitor and P-selectin as markers of sepsis-induced non-overt disseminated intravascular coagulopathy.

Authors:  Eman Mosad; Khalid I Elsayh; Azza A Eltayeb
Journal:  Clin Appl Thromb Hemost       Date:  2009-08-18       Impact factor: 2.389

10.  Acute infections and venous thromboembolism.

Authors:  M Schmidt; E Horvath-Puho; R W Thomsen; L Smeeth; H T Sørensen
Journal:  J Intern Med       Date:  2011-12-08       Impact factor: 8.989

View more
  13 in total

1.  Bothrops lanceolatus snake (Fer-de-lance) venom triggers inflammatory mediators' storm in human blood.

Authors:  Felipe Silva de França; Joel José Megale Gabrili; Laurence Mathieu; François Burgher; Joël Blomet; Denise V Tambourgi
Journal:  Arch Toxicol       Date:  2021-01-04       Impact factor: 5.153

2.  High Occurrence of Thrombo-Embolic Complications During Long-Term Follow-up After Pleural Infections-A Single-Center Experience with 536 Consecutive Patients Over 17 Years.

Authors:  Henna Maria Ala-Seppälä; Mika Tapani Ukkonen; Antti Ilmari Lehtomäki; Emilia Susanna Pohja; Jaakko Juhani Nieminen; Jari Olavi Laurikka; Jahangir Ari Khan
Journal:  Lung       Date:  2020-06-30       Impact factor: 2.584

3.  Cathrombosis: Deep Vein Thrombosis After a Cat Bite - A Case Report.

Authors:  Francisco Guadarrama-Conzuelo; Alejandro Gutierrez-Castillo
Journal:  Cureus       Date:  2019-06-17

Review 4.  Severe pulmonary tuberculosis complicated with insidious pulmonary thromboembolism: a case report and literature review.

Authors:  Lili Huang; Chunyang Yin; Xiaoyan Gu; Xiaojun Tang; Xia Zhang; Chunmei Hu; Wei Chen
Journal:  J Thromb Thrombolysis       Date:  2020-05       Impact factor: 2.300

5.  Systemic thromboemboli in patients with Covid-19 may result from paradoxical embolization.

Authors:  Rajkumar Rajendram; Ghulam Abbas Kharal; Naveed Mahmood; Mubashar Kharal
Journal:  Thromb Res       Date:  2020-09-01       Impact factor: 3.944

6.  Cytomegalovirus-Associated Venous and Arterial Thrombotic Disease.

Authors:  Amar H Kelkar; Brian L Loc; Michael D Tarantino; Anita Rajasekhar; Huaping Wang; Mona Kelkar; John Farrell
Journal:  Cureus       Date:  2020-12-18

7.  Epidemiology and Genetics of Venous Thromboembolism and Chronic Venous Disease.

Authors:  Richard A Baylis; Nicholas L Smith; Derek Klarin; Eri Fukaya
Journal:  Circ Res       Date:  2021-06-10       Impact factor: 23.213

8.  Emergence of institutional antithrombotic protocols for coronavirus 2019.

Authors:  Kevin P Cohoon; Guillaume Mahé; Alfonso J Tafur; Alex C Spyropoulos
Journal:  Res Pract Thromb Haemost       Date:  2020-06-12

Review 9.  Understanding Infection-Induced Thrombosis: Lessons Learned From Animal Models.

Authors:  Nonantzin Beristain-Covarrubias; Marisol Perez-Toledo; Mark R Thomas; Ian R Henderson; Steve P Watson; Adam F Cunningham
Journal:  Front Immunol       Date:  2019-11-05       Impact factor: 7.561

10.  Incidence of inpatient venous thromboembolism in treated patients with rheumatoid arthritis and the association with switching biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) in the real-world setting.

Authors:  Huifang Liang; Raghava Danwada; Dianlin Guo; Jeffrey R Curtis; Ryan D Kilpatrick; Barbara Hendrickson; Syed S Islam
Journal:  RMD Open       Date:  2019-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.